-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On MapLight Therapeutics with Buy Rating

Benzinga·04/07/2026 13:52:51
Listen to the news
TD Cowen analyst Joseph Thome initiates coverage on MapLight Therapeutics (NASDAQ:MPLT) with a Buy rating.